| Version |
2.5 |
| Creation Date |
2005-06-13 13:24:05 |
| Update Date |
2009-04-16 16:47:30 |
| Primary Accession Number |
DB00158 |
| Secondary Accession Number |
|
| Name |
Folic Acid |
| Drug Type |
- Approved
- Nutraceutical
- Small Molecule
|
| Description |
A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (poaceae). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. [PubChem] |
| Synonyms |
- Folate
- PGA
- Pteroyl-L-glutamic acid
- Pteroyl-L-monoglutamic acid
- Pteroylglutamic acid
- Pteroylmonoglutamic acid
- Vitamin B9
- Vitamin Bc
- Vitamin Be
- Vitamin M
|
| Brand Names |
- Acifolic
- Apo-Folic
- Cytofol
- Dosfolat B activ
- Folacid
- Folacin
- Folbal
- Folcidin
- Foldine
- Folettes
- Foliamin
- Folicet
- Folipac
- Folsan
- Folsaure
- Folsav
- Folvite
- Folvron
- Incafolic
- Millafol
|
| Brand Mixtures |
Not Available |
| Chemical IUPAC Name |
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid |
| Chemical Formula |
C19H19N7O6 |
| Chemical Structure |
 |
| CAS Registry Number |
59-30-3 |
| InChI Identifier |
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1/f/h24-25,27,31H,20H2 |
| InChI Key |
OVBPIULPVIDEAO-MIBLXQRJDO |
| KEGG Drug |
D00070  |
| KEGG Compound |
C00504  |
| PubChem Compound |
6037  |
| PubChem Substance |
3787  |
| ChEBI ID |
27470  |
| PharmGKB ID |
PA449692  |
| HET ID |
FOL  |
| GenBank ID |
Not Available |
| Drug ID Number [DIN] |
Not Available |
| RxList Link |
Not Available |
| PDRhealth Link |
http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/fol_0110.shtml  |
| Wikipedia Link |
http://en.wikipedia.org/wiki/Folic_Acid  |
| FDA Label |
Not Available |
| Material Safety Data Sheet (MSDS) |
|
| Synthesis Reference |
Not Available |
| Average Molecular Weight |
441.3975 |
| Monoisotopic Molecular Weight |
441.1397 |
| State |
Solid |
| Melting Point |
250 oC |
| Experimental Water Solubility |
Slight
Source: PhysProp
|
| Predicted Water Solubility |
7.61e-02 mg/mL
Calculated using ALOGPS
|
| Experimental LogP/Hydrophobicity |
-2.5
Source: PhysProp
|
| Predicted LogP |
-0.04
Calculated using ALOGPS
|
| Experimental LogS |
Not Available |
| Predicted LogS |
-3.76
Calculated using ALOGPS
|
| Experimental Caco2 Permeability |
Not Available |
| pKa/Isoelectric Point |
Not Available |
| Mass Spectrum |
Not Available
|
| MOL File |
Show | Download  |
| SDF File |
Show | Download  |
| PDB File |
Show | Download  |
| 2D Structure |
|
| 3D Structure |
|
| Experimental PDB ID |
1VIF  |
| Experimental PDB File |
Show |
| Experimental PDB Structure |
|
| Isomeric SMILES |
NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1 |
| Canonical SMILES |
NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)=CN=C2N1 |
| Drug Category |
- Dietary supplement
- Hematinics
- Micronutrient
- Vitamin B Complex
|
| ATC Codes |
|
| AHFS Codes |
|
| Indication |
For treatment of folic acid deficiency, megaloblastic anemia and in anemias of nutritional supplements, pregnancy, infancy, or childhood. |
| Pharmacology |
Folic acid, a water-soluble B-complex vitamin, is found in foods such as liver, kidneys, yeast, and leafy, green vegetables. Folic acid is used to diagnose folate deficiency and to treat topical sprue and megaloblastic and macrocytic anemias, hematologic complications resulting from a deficiency in folic acid. |
| Mechanism of Action |
Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase. These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase. |
| Absorption |
Not Available |
| Toxicity |
IPR-MUS LD50 85 mg/kg,IVN-GPG LD50 120 mg/kg, IVN-MUS LD50 239 mg/kg, IVN-RAT LD50 500 mg/kg, IVN-RBT LD50 410 mg/kg |
| Protein Binding |
Very high to plasma protein |
| Biotransformation |
Hepatic |
| Half Life |
Not Available |
| Dosage Forms |
| Form |
Route |
| Capsule |
Oral |
| Liquid |
Intravenous |
| Tablet |
Oral |
|
| Patient Information |
Not Available |
| Contraindications |
Not Available |
| Interactions |
Show  |
| Drug Interactions |
| Drug |
Interaction |
| Amobarbital |
Folic acid decreases the effect of anticonvulsant |
| Aprobarbital |
Folic acid decreases the effect of anticonvulsant |
| Butabarbital |
Folic acid decreases the effect of anticonvulsant |
| Butalbital |
Folic acid decreases the effect of anticonvulsant |
| Butethal |
Folic acid decreases the effect of anticonvulsant |
| Dihydroquinidine barbiturate |
Folic acid decreases the effect of anticonvulsant |
| Ethotoin |
Folic acid decreases the levels of hydantoin |
| Fosphenytoin |
Folic acid decreases the levels of hydantoin |
| Heptabarbital |
Folic acid decreases the effect of anticonvulsant |
| Hexobarbital |
Folic acid decreases the effect of anticonvulsant |
| Mephenytoin |
Folic acid decreases the levels of hydantoin |
| Methohexital |
Folic acid decreases the effect of anticonvulsant |
| Methylphenobarbital |
Folic acid decreases the effect of anticonvulsant |
| Pentobarbital |
Folic acid decreases the effect of anticonvulsant |
| Phenobarbital |
Folic acid decreases the effect of anticonvulsant |
| Phenytoin |
Folic acid decreases the levels of hydantoin |
| Primidone |
Folic acid decreases the effect of anticonvulsant |
| Quinidine barbiturate |
Folic acid decreases the effect of anticonvulsant |
| Secobarbital |
Folic acid decreases the effect of anticonvulsant |
| Talbutal |
Folic acid decreases the effect of anticonvulsant |
|
| Food Interactions |
Not Available
|
| Pathways |
Not Available
|
| General References |
- Alaimo K, McDowell MA, Briefel RR, Bischof AM, Caughman CR, Loria CM, Johnson CL: Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. Adv Data. 1994 Nov 14;(258):1-28. [PubMed
]
- Raiten DJ, Fisher KD: Assessment of folate methodology used in the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). J Nutr. 1995 May;125(5):1371S-1398S. [PubMed
]
- Zittoun J: [Anemias due to disorder of folate, vitamin B12 and transcobalamin metabolism] Rev Prat. 1993 Jun 1;43(11):1358-63. [PubMed
]
- Kamen B: Folate and antifolate pharmacology. Semin Oncol. 1997 Oct;24(5 Suppl 18):S18-30-S18-39. [PubMed
]
- Fenech M, Aitken C, Rinaldi J: Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis. 1998 Jul;19(7):1163-71. [PubMed
]
- Wikipedia

- PDRhealth

|
| Organisms Affected |
|
| Phase 1 Metabolizing Enzymes |
- Catechol O-methyltransferase (COMT)
- Methylenetetrahydrofolate reductase
|
| Targets |
- Gamma-glutamyl hydrolase
- Folate receptor beta
- Folate receptor gamma
- Mitochondrial folate transporter/carrier
- Heme carrier protein 1
|
|
Drug Target 1
[top]
|
| Target 1 ID |
293 |
| Target 1 Name |
Gamma-glutamyl hydrolase |
| Target 1 Synonyms |
- Conjugase
- EC 3.4.19.9
- GH
- Gamma-Glu-X carboxypeptidase
- Gamma-glutamyl hydrolase precursor
|
| Target 1 Gene Name |
GGH |
| Target 1 Protein Sequence |
>Gamma-glutamyl hydrolase precursor
MASPGCLLCVLGLLLCGAASLELSRPHGDTAKKPIIGILMQKCRNKVMKNYGRYYIAASY
VKYLESAGARVVPVRLDLTEKDYEILFKSINGILFPGGSVDLRRSDYAKVAKIFYNLSIQ
SFDDGDYFPVWGTCLGFEELSLLISGECLLTATDTVDVAMPLNFTGGQLHSRMFQNFPTE
LLLSLAVEPLTANFHKWSLSVKNFTMNEKLKKFFNVLTTNTDGKIEFISTMEGYKYPVYG
VQWHPEKAPYEWKNLDGISHAPNAVKTAFYLAEFFVNEARKNNHHFKSESEEEKALIYQF
SPIYTGNISSFQQCYIFD
|
| Target 1 Number of Residues |
323 |
| Target 1 Molecular Weight |
35965 |
| Target 1 Theoretical pI |
7.14 |
| Target 1 GO Classification |
|
Function
|
| catalytic activity |
|
Process
|
physiological process
metabolism
cellular metabolism
amino acid and derivative metabolism
amino acid metabolism
glutamine family amino acid metabolism
glutamine metabolism |
|
Component
|
| Not Available |
|
| Target 1 General Function |
Involved in gamma-gluatmyl hydrolase activity |
| Target 1 Specific Function |
Hydrolyzes the polyglutamate sidechains of pteroylpolyglutamates. Progressively removes gamma-glutamyl residues from pteroylpoly-gamma-glutamate to yield pteroyl-alpha- glutamate (folic acid) and free glutamate. May play an important role in the bioavailability of dietary pteroylpolyglutamates and in the metabolism of pteroylpolyglutamates and antifolates |
| Target 1 Pathways |
| Name |
SMPDB Link |
KEGG Link |
| Folate biosynthesis |
|
map00790  |
|
| Target 1 Reactions |
- Hydrolysis of a gamma-glutamyl bond ALL_REAC (other) R04242
|
| Target 1 Pfam Domain Function |
|
| Target 1 Signals |
|
| Target 1 Transmembrane Regions |
|
| Target 1 Essentiality |
Non-Essential |
| Target 1 GenBank ID Protein |
2951931  |
| Target 1 UniProtKB/Swiss-Prot ID |
Q92820  |
| Target 1 UniProtKB/Swiss-Prot Entry Name |
GGH_HUMAN  |
| Target 1 PDB ID |
1L9X  |
| Target 1 PDB File |
Show |
| Target 1 3D Structure |
|
| Target 1 Cellular Location |
- Secreted protein
- extracellular space. Lysosome. While its intracellular location is primarily the l
|
| Target 1 Gene Sequence |
>957 bp
ATGGCCAGTCCGGGCTGCCTGCTGTGCGTGCTGGGCCTGCTACTCTGCGGGGCGGCGAGC
CTCGAGCTGTCTAGACCCCACGGCGACACCGCCAAGAAGCCCATCATCGGAATATTAATG
CAAAAATGCCGTAATAAAGTCATGAAAAACTATGGAAGATACTATATTGCTGCGTCCTAT
GTAAAGTACTTGGAGTCTGCAGGTGCGAGAGTTGTACCAGTAAGGCTGGATCTTACAGAG
AAAGACTATGAAATACTTTTCAAATCTATTAATGGAATCCTTTTCCCTGGAGGAAGTGTT
GACCTCAGACGCTCAGATTATGCTAAAGTGGCCAAAATATTTTATAACTTGTCCATACAG
AGTTTTGATGATGGAGACTATTTTCCTGTGTGGGGCACATGCCTTGGATTTGAAGAGCTT
TCACTGCTGATTAGTGGAGAGTGCTTATTAACTGCCACAGATACTGTTGACGTGGCAATG
CCGCTGAACTTCACTGGAGGTCAATTGCACAGCAGAATGTTCCAGAATTTTCCTACTGAG
TTGTTGCTGTCATTAGCAGTAGAACCTCTGACTGCCAATTTCCATAAGTGGAGCCTCTCC
GTGAAGAATTTTACAATGAATGAAAAGTTAAAGAAGTTTTTCAATGTCTTAACTACAAAT
ACAGATGGCAAGATTGAGTTTATTTCAACAATGGAAGGATATAAGTATCCAGTATATGGT
GTCCAGTGGCATCCAGAGAAAGCACCTTATGAGTGGAAGAATTTGGATGGCATTTCCCAT
GCACCTAATGCTGTGAAAACCGCATTTTATTTAGCAGAGTTTTTTGTTAATGAAGCTCGG
AAAAACAACCATCATTTTAAATCTGAATCTGAAGAGGAGAAAGCATTGATTTATCAGTTC
AGTCCAATTTATACTGGAAATATTTCTTCATTTCAGCAATGTTACATATTTGATTGA
|
| Target 1 GenBank Gene ID |
|
| Target 1 GeneCard ID |
GGH  |
| Target 1 GenAtlas ID |
GGH  |
| Target 1 HGNC ID |
HGNC:4248  |
| Target 1 Chromosome Location |
8 |
| Target 1 Locus |
8q12.3 |
| Target 1 SNPs |
SNPJam Report  |
| Target 1 General References |
- Yin D, Chave KJ, Macaluso CR, Galivan J, Yao R: Structural organization of the human gamma-glutamyl hydrolase gene. Gene. 1999 Oct 1;238(2):463-70. [PubMed
]
- Yao R, Schneider E, Ryan TJ, Galivan J: Human gamma-glutamyl hydrolase: cloning and characterization of the enzyme expressed in vitro. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10134-8. [PubMed
]
|
| Target 1 Drug References |
- Schneider E, Ryan TJ: Gamma-glutamyl hydrolase and drug resistance. Clin Chim Acta. 2006 Dec;374(1-2):25-32. Epub 2006 Jun 10. [PubMed
]
- Eisele LE, Chave KJ, Lehning AC, Ryan TJ: Characterization of Human gamma-glutamyl hydrolase in solution demonstrates that the enzyme is a non-dissociating homodimer. Biochim Biophys Acta. 2006 Sep;1764(9):1479-86. Epub 2006 Jul 12. [PubMed
]
- Chen L, Eitenmiller RR: Optimization of the trienzyme extraction for the microbiological assay of folate in vegetables. J Agric Food Chem. 2007 May 16;55(10):3884-8. Epub 2007 Apr 17. [PubMed
]
|
|
Drug Target 2
[top]
|
| Target 2 ID |
299 |
| Target 2 Name |
Folate receptor beta |
| Target 2 Synonyms |
- FBP
- FR-beta
- Folate receptor 2
- Folate receptor beta precursor
- Folate receptor, fetal/placental
- Placental folate-binding protein
|
| Target 2 Gene Name |
FOLR2 |
| Target 2 Protein Sequence |
>Folate receptor beta precursor
MVWKWMPLLLLLVCVATMCSAQDRTDLLNVCMDAKHHKTKPGPEDKLHDQCSPWKKNACC
TASTSQELHKDTSRLYNFNWDHCGKMEPACKRHFIQDTCLYECSPNLGPWIQQVNQSWRK
ERFLDVPLCKEDCQRWWEDCHTSHTCKSNWHRGWDWTSGVNKCPAGALCRTFESYFPTPA
ALCEGLWSHSYKVSNYSRGSGRCIQMWFDSAQGNPNEEVARFYAAAMHVNAGEMLHGTGG
LLLSLALMLQLWLLG
|
| Target 2 Number of Residues |
259 |
| Target 2 Molecular Weight |
29280 |
| Target 2 Theoretical pI |
7.56 |
| Target 2 GO Classification |
Not Available |
| Target 2 General Function |
Involved in folic acid binding |
| Target 2 Specific Function |
Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate to the interior of cells |
| Target 2 Pathways |
Not Available
|
| Target 2 Reactions |
Not Available |
| Target 2 Pfam Domain Function |
|
| Target 2 Signals |
|
| Target 2 Transmembrane Regions |
|
| Target 2 Essentiality |
Non-Essential |
| Target 2 GenBank ID Protein |
1655592  |
| Target 2 UniProtKB/Swiss-Prot ID |
P14207  |
| Target 2 UniProtKB/Swiss-Prot Entry Name |
FOLR2_HUMAN  |
| Target 2 PDB ID |
Not Available |
| Target 2 Cellular Location |
- Cell membrane
- GPI-anchor. Secreted protein (Probable)
- lipid-anchor
|
| Target 2 Gene Sequence |
>768 bp
ATGGTCTGGAAATGGATGCCACTTCTGCTGCTTCTGGTCTGTGTAGCCACCATGTGCAGT
GCCCAGGACAGGACTGATCTCCTCAATGTCTGTATGGATGCCAAGCACCACAAGACAAAG
CCAGGTCCTGAGGACAAGCTGCATGACCAATGCAGTCCCTGGAAGAAGAATGCCTGCTGC
ACAGCCAGCACCAGCCAGGAGCTGCACAAGGACACCTCCCGCCTGTACAACTTTAACTGG
GACCACTGCGGCAAGATGGAGCCCGCCTGCAAGCGCCACTTCATCCAGGACACCTGTCTC
TATGAGTGCTCACCCAACCTGGGGCCCTGGATCCAGCAGGTGAATCAGAGCTGGCGCAAA
GAACGCTTCCTGGATGTGCCCTTATGCAAAGAGGACTGTCAGCGCTGGTGGGAGGATTGT
CACACCTCCCACACGTGCAAGAGCAACTGGCACAGAGGATGGGACTGGACCTCAGGAGTT
AACAAGTGCCCAGCTGGGGCTCTCTGCCGCACCTTTGAGTCCTACTTCCCCACTCCAGCT
GCCCTTTGTGAAGGCCTCTGGAGTCACTCATACAAGGTCAGCAACTACAGCCGAGGGAGC
GGCCGCTGCATCCAGATGTGGTTTGATTCAGCCCAGGGCAACCCCAACGAGGAAGTGGCG
AGGTTCTATGCTGCAGCCATGCATGTGAATGCAGGTGAGATGCTTCATGGGACTGGGGGT
CTCCTGCTCAGTCTGGCCCTGATGCTGCAACTCTGGCTCCTTGGCTGA
|
| Target 2 GenBank Gene ID |
|
| Target 2 GeneCard ID |
FOLR2  |
| Target 2 GenAtlas ID |
FOLR2  |
| Target 2 HGNC ID |
HGNC:3793  |
| Target 2 Chromosome Location |
11 |
| Target 2 Locus |
11q13.3-q13.5 |
| Target 2 SNPs |
SNPJam Report  |
| Target 2 General References |
- Freisheim JH, Price EM, Ratnam M: Folate coenzyme and antifolate transport proteins in normal and neoplastic cells. Adv Enzyme Regul. 1989;29:13-26. [PubMed
]
- Ratnam M, Marquardt H, Duhring JL, Freisheim JH: Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry. 1989 Oct 3;28(20):8249-54. [PubMed
]
- Yan W, Ratnam M: Preferred sites of glycosylphosphatidylinositol modification in folate receptors and constraints in the primary structure of the hydrophobic portion of the signal. Biochemistry. 1995 Nov 7;34(44):14594-600. [PubMed
]
- Sadasivan E, Cedeno MM, Rothenberg SP: Characterization of the gene encoding a folate-binding protein expressed in human placenta. Identification of promoter activity in a G-rich SP1 site linked with the tandemly repeated GGAAG motif for the ets encoded GA-binding protein. J Biol Chem. 1994 Feb 18;269(7):4725-35. [PubMed
]
- Page ST, Owen WC, Price K, Elwood PC: Expression of the human placental folate receptor transcript is regulated in human tissues. Organization and full nucleotide sequence of the gene. J Mol Biol. 1993 Feb 20;229(4):1175-83. [PubMed
]
- Wang J, Shen F, Yan W, Wu M, Ratnam M: Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion. Biochemistry. 1997 Nov 25;36(47):14583-92. [PubMed
]
|
| Target 2 Drug References |
- Wlodarczyk BJ, Cabrera RM, Hill DS, Bozinov D, Zhu H, Finnell RH: Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos. Neurotoxicology. 2006 Jul;27(4):547-57. Epub 2006 Apr 18. [PubMed
]
- Dixit V, Van den Bossche J, Sherman DM, Thompson DH, Andres RP: Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells. Bioconjug Chem. 2006 May-Jun;17(3):603-9. [PubMed
]
- Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, Nijhout HF, George TM, Enterline DS, Gilbert JR, Speer MC: Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect. 2006 Oct;114(10):1547-52. [PubMed
]
|
|
Drug Target 3
[top]
|
| Target 3 ID |
718 |
| Target 3 Name |
Folate receptor gamma |
| Target 3 Synonyms |
- FR-gamma
- Folate receptor 3
- Folate receptor gamma precursor
|
| Target 3 Gene Name |
FOLR3 |
| Target 3 Protein Sequence |
>Folate receptor gamma precursor
MAWQMMQLLLLALVTAAGSAQPRSARARTDLLNVCMNAKHHKTQPSPEDELYGQCSPWKK
NACCTASTSQELHKDTSRLYNFNWDHCGKMEPTCKRHFIQDSCLYECSPNLGPWIRQVNQ
SWRKERILNVPLCKEDCERWWEDCRTSYTCKSNWHKGWNWTSGINECPAGALCSTFESYF
PTPAALCEGLWSHSFKVSNYSRGSGRCIQMWFDSAQGNPNEEVAKFYAAAMNAGAPSRGI
IDS
|
| Target 3 Number of Residues |
247 |
| Target 3 Molecular Weight |
27638 |
| Target 3 Theoretical pI |
7.88 |
| Target 3 GO Classification |
Not Available |
| Target 3 General Function |
Involved in folic acid binding |
| Target 3 Specific Function |
Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate to the interior of cells. Isoform Short does not bind folate |
| Target 3 Pathways |
Not Available
|
| Target 3 Reactions |
Not Available |
| Target 3 Pfam Domain Function |
|
| Target 3 Signals |
|
| Target 3 Transmembrane Regions |
|
| Target 3 Essentiality |
Non-Essential |
| Target 3 GenBank ID Protein |
473236  |
| Target 3 UniProtKB/Swiss-Prot ID |
P41439  |
| Target 3 UniProtKB/Swiss-Prot Entry Name |
FOLR3_HUMAN  |
| Target 3 PDB ID |
Not Available |
| Target 3 Cellular Location |
|
| Target 3 Gene Sequence |
>732 bp
ATGGCCTGGCAGATGATGCAGCTGCTGCTTCTGGCTTTGGTGACTGCTGCGGGGAGTGCC
CAGCCCAGGAGTGCGCGGGCCAGGACGGACCTGCTCAATGTCTGCATGAACGCCAAGCAC
CACAAGACACAGCCCAGCCCCGAGGACGAGCTGTATGGCCAGTGCAGTCCCTGGAAGAAG
AATGCCTGCTGCACGGCCAGCACCAGCCAGGAGCTGCACAAGGACACCTCCCGCCTGTAC
AACTTTAACTGGGATCACTGTGGTAAGATGGAACCCACCTGCAAGCGCCACTTTATCCAG
GACAGCTGTCTCTATGAGTGCTCACCCAACCTGGGGCCCTGGATCCGGCAGGTCAACCAG
AGCTGGCGCAAAGAGCGCATTCTGAACGTGCCCCTGTGCAAAGAGGACTGTGAGCGCTGG
TGGGAGGACTGTCGCACCTCCTACACCTGCAAAAGCAACTGGCACAAAGGCTGGAATTGG
ACCTCAGGGATTAATGAGTGTCCGGCCGGGGCCCTCTGCAGCACCTTTGAGTCCTACTTC
CCCACTCCAGCCGCCCTTTGTGAAGGCCTCTGGAGCCACTCCTTCAAGGTCAGCAACTAT
AGTCGAGGGAGCGGCCGCTGCATCCAGATGTGGTTTGACTCAGCCCAGGGCAACCCCAAT
GAGGAGGTGGCCAAGTTCTATGCTGCGGCCATGAATGCTGGGGCCCCGTCTCGTGGGATT
ATTGATTCCTGA
|
| Target 3 GenBank Gene ID |
|
| Target 3 GeneCard ID |
FOLR3  |
| Target 3 GenAtlas ID |
FOLR3  |
| Target 3 HGNC ID |
HGNC:3795  |
| Target 3 Chromosome Location |
11 |
| Target 3 Locus |
11q13 |
| Target 3 SNPs |
SNPJam Report  |
| Target 3 General References |
- Shen F, Wu M, Ross JF, Miller D, Ratnam M: Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity. Biochemistry. 1995 Apr 25;34(16):5660-5. [PubMed
]
- Shen F, Ross JF, Wang X, Ratnam M: Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry. 1994 Feb 8;33(5):1209-15. [PubMed
]
|
| Target 3 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
- Shen F, Wu M, Ross JF, Miller D, Ratnam M: Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity. Biochemistry. 1995 Apr 25;34(16):5660-5. [PubMed
]
- Prasad PD, Ramamoorthy S, Moe AJ, Smith CH, Leibach FH, Ganapathy V: Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells. Biochim Biophys Acta. 1994 Aug 11;1223(1):71-5. [PubMed
]
- Shen F, Ross JF, Wang X, Ratnam M: Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry. 1994 Feb 8;33(5):1209-15. [PubMed
]
|
|
Drug Target 4
[top]
|
| Target 4 ID |
804 |
| Target 4 Name |
Mitochondrial folate transporter/carrier |
| Target 4 Synonyms |
- Solute carrier family 25 member 32
|
| Target 4 Gene Name |
SLC25A32 |
| Target 4 Protein Sequence |
>Mitochondrial folate transporter/carrier
MTGQGQSASGSSAWSTVFRHVRYENLIAGVSGGVLSNLALHPLDLVKIRFAVSDGLELRP
KYNGILHCLTTIWKLDGLRGLYQGVTPNIWGAGLSWGLYFFFYNAIKSYKTEGRAERLEA
TEYLVSAAEAGAMTLCITNPLWVTKTRLMLQYDAVVNSPHRQYKGMFDTLVKIYKYEGVR
GLYKGFVPGLFGTSHGALQFMAYELLKLKYNQHINRLPEAQLSTVEYISVAALSKIFAVA
ATYPYQVVRARLQDQHMFYSGVIDVITKTWRKEGVGGFYKGIAPNLIRVTPACCITFVVY
ENVSHFLLDLREKRK
|
| Target 4 Number of Residues |
320 |
| Target 4 Molecular Weight |
35408 |
| Target 4 Theoretical pI |
9.79 |
| Target 4 GO Classification |
|
Function
|
binding
transporter activity |
|
Process
|
physiological process
cellular physiological process
transport |
|
Component
|
cell
membrane
organelle membrane
organelle inner membrane
mitochondrial inner membrane |
|
| Target 4 General Function |
Involved in folate transporter activity |
| Target 4 Specific Function |
Transports folate across the inner membranes of mitochondria |
| Target 4 Pathways |
Not Available
|
| Target 4 Reactions |
Not Available |
| Target 4 Pfam Domain Function |
|
| Target 4 Signals |
|
| Target 4 Transmembrane Regions |
|
| Target 4 Essentiality |
Non-Essential |
| Target 4 GenBank ID Protein |
11545417  |
| Target 4 UniProtKB/Swiss-Prot ID |
Q9H2D1  |
| Target 4 UniProtKB/Swiss-Prot Entry Name |
MFTC_HUMAN  |
| Target 4 PDB ID |
Not Available |
| Target 4 Cellular Location |
- Mitochondrion
- mitochondrial inner membrane
- multi-pass membrane protein
|
| Target 4 Gene Sequence |
>948 bp
ATGACGGGCCAGGGCCAGTCGGCGTCCGGGTCGTCGGCGTGGAGCACGGTATTCCGCCAC
GTCCGGTATGAGAACCTGATAGCGGGCGTGAGCGGCGGCGTCTTATCCAACCTTGCGCTG
CATCCGCTCGACCTCGTGAAGATCCGCTTCGCCGTGAGTGATGGATTGGAACTGAGACCG
AAATATAATGGAATTTTACATTGCTTGACTACCATTTGGAAACTTGATGGACTACGGGGA
CTTTATCAAGGAGTAACCCCAAATATATGGGGTGCAGGTTTATCCTGGGGACTCTACTTT
TTCTTTTACAATGCCATCAAGTCATATAAAACAGAAGGAAGAGCTGAACATTTAGAGGCA
ACAGAATACCTTGTCTCAGCTGCTGAAGCTGGAGCCATGACCCTCTGCATTACAAACCCA
TTATGGGTAACAAAAACTCGCCTTATGTTACAGTATGATGCTGTTGTTAACTCCCCACAC
CGACAATATAAAGGAATGTTTGATACACTTGTGAAAATATATAAGTATGAAGGTGTGCGT
GGATTATATAAGGGATTTGTTCCTGGGCTGTTTGGAACATCGCATGGTGCCCTTCAGTTT
ATGGCATATGAATTGCTGAAGTTGAAGTACAACCAGCATATCAATAGATTACCAGAAGCC
CAGTTGAGCACAGTAGAATATATATCTGTTGCAGCACTATCCAAAATATTTGCTGTCGCA
GCAACATACCCATATCAAGTCGTAAGAGCTCGTCTTCAGGATCAACACATGTTTTACAGT
GGTGTAATAGATGTAATCACAAAGACATGGAGGAAAGAAGGCGTCGGTGGATTTTACAAG
GGAATTGCTCCTAATTTGATTAGAGTGACTCCAGCCTGCTGTATTACCTTTGTGGTATAT
GAAAACGTCTCACATTTTTTACTTGACCTTAGAGAAAAGAGAAAGTAA
|
| Target 4 GenBank Gene ID |
|
| Target 4 GeneCard ID |
SLC25A32  |
| Target 4 GenAtlas ID |
SLC25A32  |
| Target 4 HGNC ID |
HGNC:29683  |
| Target 4 Chromosome Location |
8 |
| Target 4 Locus |
8q22.3 |
| Target 4 SNPs |
SNPJam Report  |
| Target 4 General References |
- Titus SA, Moran RG: Retrovirally mediated complementation of the glyB phenotype. Cloning of a human gene encoding the carrier for entry of folates into mitochondria. J Biol Chem. 2000 Nov 24;275(47):36811-7. [PubMed
]
|
| Target 4 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 5
[top]
|
| Target 5 ID |
1650 |
| Target 5 Name |
Heme carrier protein 1 |
| Target 5 Synonyms |
Not Available |
| Target 5 Gene Name |
HCP1 |
| Target 5 Protein Sequence |
>Heme carrier protein 1
MEGSASPPEKPRARPAAAVLCRGPVEPLVFLANFALVLQGPLTTQYLWHRFSADLGYNGT
RQRGGCSNRSADPTMQEVETLTSHWTLYMNVGGFLVGLFSSTLLGAWSDSVGRRPLLVLA
SLGLLLQALVSVFVVQLQLHVGYFVLGRILCALLGDFGGLLAASFASVADVSSSRSRTFR
MALLEASIGVAGMLASLLGGHWLRAQGYANPFWLALALLIAMTLYAAFCFGETLKEPKST
RLFTFRHHRSIVQLYVAPAPEKSRKHLALYSLAIFVVITVHFGAQDILTLYELSTPLCWD
SKLIGYGSAAQHLPYLTSLLALKLLQYCLADAWVAEIGLAFNILGMVVFAFATITPLMFT
GYGLLFLSLVITPVIRAKLSKLVRETEQGALFSAVACVNSLAMLTASGIFNSLYPATLNF
MKGFPFLLGAGLLLIPAVLIGMLEKADPHLEFQQFPQSP
|
| Target 5 Number of Residues |
466 |
| Target 5 Molecular Weight |
49771 |
| Target 5 Theoretical pI |
8.97 |
| Target 5 GO Classification |
|
Function
|
| transporter activity |
|
Process
|
physiological process
cellular physiological process
transport |
|
Component
|
cell
membrane
intrinsic to membrane
integral to membrane |
|
| Target 5 General Function |
Carbohydrate transport and metabolism |
| Target 5 Specific Function |
Intestinal heme transporter which mediates heme uptake from the gut lumen into duodenal epithelial cells; the iron is then released from heme and may be transported into the bloodstream. Dietary heme iron is an important nutritional source of iron |
| Target 5 Pathways |
Not Available
|
| Target 5 Reactions |
Not Available |
| Target 5 Pfam Domain Function |
|
| Target 5 Signals |
|
| Target 5 Transmembrane Regions |
- 87-107
- 115-135
- 149-169
- 183-203
- 211-231
- 267-287
- 303-325
- 337-357
- 359-379
- 390-410
- 423-443
|
| Target 5 Essentiality |
Non-Essential |
| Target 5 GenBank ID Protein |
16549261  |
| Target 5 UniProtKB/Swiss-Prot ID |
Q96NT5  |
| Target 5 UniProtKB/Swiss-Prot Entry Name |
HCP1_HUMAN  |
| Target 5 PDB ID |
Not Available |
| Target 5 Cellular Location |
- Cell membrane
- apical cell membrane
- multi- pass membrane protein. Membrane
- multi-pass membrane pro
|
| Target 5 Gene Sequence |
>1380 bp
ATGGAGGGGAGCGCGAGCCCCCCGGAAAAGCCCCGCGCCCGCCCTGCGGCTGCCGTGCTG
TGCCGGGGCCCGGTAGAGCCGCTGGTCTTCCTGGCCAACTTTGCCTTGGTCCTGCAGGGC
CCGCTCACCACGCAGTATCTGTGGCACCGCTTCAGCGCCGACCTCGGCTACAATGGCACC
CGCCAAAGGGGGGGCTGCAGCAACCGCAGCGCGGACCCCACCATGCAGGAAGTGGAGACC
CTTACCTCCCACTGGACCCTCTACATGAACGTGGGCGGCTTCCTGGTGGGGCTCTTCTCG
TCCACCCTGCTGGGAGCTTGGAGCGACAGTGTGGGCCGCCGCCCGCTGCTAGTGCTGGCC
TCGCTGGGCCTGCTGCTCCAGGCCCTAGTGTCCGTTTTTGTGGTGCAGCTGCAGCTCCAC
GTCGGCTACTTCGTGCTGGGTCGCATCCTTTGTGCCCTCCTCGGCGACTTCGGTGGCCTT
CTGGCTGCTAGCTTTGCGTCCGTGGCAGATGTCAGCTCCAGTCGCAGCCGCACCTTCCGG
ATGGCCCTGCTAGAAGCCAGCATCGGGGTGGCTGGGATGCTGGCAAGCCTCCTCGGGGGC
CACTGGCTCCGGGCCCAGGGTTATGCCAACCCCTTCTGGCTGGCCTTGGCCTTGCTGATA
GCCATGACTCTCTATGCAGCTTTCTGCTTTGGTGAGACCTTAAAGGAGCCAAAGTCCACC
CGGCTCTTCACGTTCCGTCACCACCGATCCATTGTCCAGCTCTATGTGGCTCCCGCCCCA
GAGAAGTCCAGGAAACATTTAGCCCTCTACTCACTGGCCATCTTCGTGGTGATCACTGTG
CACTTTGGGGCCCAGGACATCTTAACCCTTTATGAACTAAGCACACCCCTCTGCTGGGAC
TCCAAACTAATCGGCTATGGTTCTGCAGCTCAGCATCTCCCCTACCTCACCAGCCTGCTG
GCCCTGAAGCTCCTGCAGTACTGCCTGGCCGATGCCTGGGTAGCTGAGATCGGCCTGGCC
TTCAACATCCTGGGGATGGTGGTCTTTGCCTTTGCCACTATCACGCCTCTCATGTTCACA
GGATATGGGTTGCTTTTCCTGTCATTAGTCATCACACCTGTCATCCGGGCTAAACTCTCC
AAGCTGGTGAGAGAGACAGAGCAGGGTGCTCTCTTTTCTGCTGTGGCCTGTGTGAATAGC
CTGGCCATGCTGACGGCCTCCGGCATCTTCAACTCACTCTACCCAGCCACTCTGAACTTT
ATGAAGGGGTTCCCCTTCCTCCTGGGAGCTGGCCTCCTGCTCATCCCGGCTGTTCTGATT
GGGATGCTGGAAAAGGCTGATCCTCACCTCGAGTTCCAGCAGTTTCCCCAGAGCCCCTGA
|
| Target 5 GenBank Gene ID |
|
| Target 5 GeneCard ID |
SLC46A1  |
| Target 5 GenAtlas ID |
SLC46A1  |
| Target 5 HGNC ID |
HGNC:30521  |
| Target 5 Chromosome Location |
Not Available |
| Target 5 Locus |
Not Available |
| Target 5 SNPs |
SNPJam Report  |
| Target 5 General References |
Not Available |
| Target 5 Drug References |
- Nakai Y, Inoue K, Abe N, Hatakeyama M, Ohta KY, Otagiri M, Hayashi Y, Yuasa H: Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter. J Pharmacol Exp Ther. 2007 Aug;322(2):469-76. Epub 2007 May 2. [PubMed
]
- Ashokkumar B, Mohammed ZM, Vaziri ND, Said HM: Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. Am J Clin Nutr. 2007 Jul;86(1):159-66. [PubMed
]
|